Bosutinib interferes with the growth of some cancer cells. Bosutinib is used to treat a type of blood cancer called Philadelphia chromosome positive chronic myelogenous leukemia (CML). Bosutinib is usually given after other similar medications have been tried without success. Bosutinib may also be used for purposes not listed in this medication guide.
Bosulif works by interfering with the growth of particular cancer cells. Bosulif is administered for the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia (CML), a type of blood cancer. Bosulif is given after other similar drugs have been used without success. Sometimes, Bosulif is used in other cancer types as part of clinical trials.